| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |